Search This Blog

Thursday, November 2, 2023

Biomarin pharmaceutical: Barclaysprice target reduced from USD 125 to USD 111.

  maintains its overweight recommendation

https://www.marketscreener.com/quote/stock/BIOMARIN-PHARMACEUTICAL-I-8587/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)